A Scientific Partnership with Conquer Cancer, The ASCO Foundation
In 2019, Gateway announced a scientific partnership with Conquer Cancer®, the ASCO Foundation, to establish the Gateway Discovery Grant Program. The biennial $1.5 million award supports early phase clinical trials with the greatest potential to advance breakthrough cancer research. The first Gateway Discovery Grant, awarded in 2020, focuses on immunotherapy.
Gateway and Conquer Cancer® now seek proposals for the second Gateway Discovery Grant which will provide three to five years of funding to catalyze innovative clinical research with a strong potential impact on mitigating cancer health disparities. The Phase I or Phase II clinical trial may include the study of any cancer type and must propose research that will contribute to the improved diagnosis and/or treatment of cancers found to disproportionately affect underrepresented populations. To help improve equitable care for all people with cancer, this second Gateway Discovery Grant will support research that specifically aims to reduce disparities related to factors such as race and ethnicity, age, gender, geography, education and other socioeconomic indicators that may impact outcomes.
More information about this grant funding opportunity is available at asco.org/Gateway.
Questions regarding this grant program, or submitting an LOI, may be e-mailed to Research@GatewayCR.org or answered via phone at 847.342.6976
Gateway's significant funding, combined with Conquer Cancer's high-caliber peer review, will provide vital support for cancer research that is essential to making progress against cancer and giving people with cancer more effective treatment options.
Fund One Day
It costs just $16.56 per patient per day in a Gateway-funded cancer clinical trial.
Help us fund another day of research, another week or more. You can even mark your gift with a special date, such as an anniverary, birthday, wedding, bar/bat mitzvah or graduation.